The World Health Organization (WHO) classification of the myeloid neoplasms.
Explore this paper's citation graph
Summary
The purpose of this communication is to outline briefly the WHO classification of malignant myeloid diseases, to draw attention to major differences between it and antecedent classification schemes, and to provide the rationale for those differences.
- Type
- review
- Published
- 2002-10-01
- Cited by
- 2,305
- References
- 113
- Access
- Open access
- OpenAlex
- https://openalex.org/W2096638244
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:9413654
Keywords
Hematopathology, Medicine, Myeloid, Lymphoma, Pathology
References
- De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance.
- Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment.
- Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung.
- Revised classification of acute myeloid leukemia.
- Diagnosis and classification of the polycythemias.
- Physical mapping of the human ATX1 homologue (HAH1) to the critical region of the 5q- syndrome within 5q32, and immediately adjacent to the SPARC gene
- Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome.
- Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
- International scoring system for evaluating prognosis in myelodysplastic syndromes.
- Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7
- The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
- Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.
- Tumors of the bone marrow
- Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
- The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
- Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases.
- Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.
- Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
- Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
- A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.
Cited by
- Vascular density and bone marrow fibrosis in childhood acute lymphoblastic leukemia
- Myeloproliferative syndromes: diagnosis and therapeutic options.
- Impact of breast cancer resistance protein on cancer treatment outcomes.
- Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.
- High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia
- Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses
- Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes.
- Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders
- Oncogenes in Myeloproliferative Disorders
- Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.
- Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine.
- A nonrandom association between gastrointestinal stromal tumors and myeloid leukemia
- Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia
- Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia
- The role of the Platelet Function Analyzer (PFA)-100 and platelet aggregometry in the differentiation of essential thrombocythemia from reactive thrombocytosis.
- Hematopoietic stem cell transplantation for myelodysplastic syndrome.
- Expression of syncytin in leukemia and lymphoma cells.
- Direct inhibition of human acute myeloid leukemia cell growth by IL-12.
- Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine.
- Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR–ABL kinase domain mutations affect patient survival? First multicenter Argentinean study
Related papers
- Genentech taps Affimed’s antibodies
- KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria
- Cardiac retransplantation in children.
- Avaliacao hemodinamica sequencial em transplante de coracao
- Korean Pediatric/Adolescent Lymphoma - Incidence and Pathologic Characteristics
- Neoplasms derived from plasmacytoid dendritic cells
- The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.